Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients

It is critical to protect immunocompromised patients against COVID-19 with effective SARS-CoV-2 vaccination as they have an increased risk of developing severe disease. This is challenging, however, since effective mRNA vaccination requires the successful cooperation of several components of the inn...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Frédéric, Canti, Lorenzo, Ariën, Kevin K., Kemlin, Delphine, Desombere, Isabelle, Gerbaux, Margaux, Pannus, Pieter, Beguin, Yves, Marchant, Arnaud, Humblet-Baron, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931657/
https://www.ncbi.nlm.nih.gov/pubmed/35309332
http://dx.doi.org/10.3389/fimmu.2022.827242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931657/
https://www.ncbi.nlm.nih.gov/pubmed/35309332
http://dx.doi.org/10.3389/fimmu.2022.827242

Ejemplares similares